|
|
|
Cataract Clinical Trials |
|
Thank you for your interest in clinical trials for Cataract and the surrounding suburbs. Please view all available clinical trials in Cataract below.
If you receive too many clinical trial listings you may enter keywords and/or reduce search distance.
|
|
|
|
|
Results from Clinical Connection:
|
|
Your Search Returned No Results. |
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 102 studies:
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-54650
Conditions: Alzheimer's Disease
Location: La Crosse, WI
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL) - NCT00774345-54601
Conditions: B-cell Chronic Lymphocytic Leukemia
Location: La Crosse, WI
- Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer - NCT00074152-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer - NCT00070564-54601A
Conditions: Breast Cancer
Location: La Crosse, WI
- Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer - NCT00070564-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D - NCT00490139-54601A
Conditions: Breast Cancer
Location: Chillicothe, OH
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D - NCT00490139-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D - NCT00490139-54601C
Conditions: Breast Cancer
Location: La Crosse, WI
- An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease - NCT00939783-54601
Conditions: Alzheimer's Disease
Location: La Crosse, WI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-54601
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation
Location: Lacrosse, WI
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer - NCT00309985-54601
Conditions: Prostate Cancer
Location: La Crosse, WI
- Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia - NCT00313586-54601
Conditions: Leukemia - Myelodysplastic Syndromes
Location: La Crosse, WI
- Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II or Stage III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - NCT00951496-54601
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: La Crosse, WI
- Bevacizumab and Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone in Treating Patients With Locally Recurrent, Stage IIIB, or Stage IV Breast Cancer - NCT00785291-54601
Conditions: Breast Cancer - Chemotherapeutic Agent Toxicity - Long-term Effects Secondary to Cancer Therapy in Adults - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: La Crosse, WI
- Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma - NCT00410605-54601
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: La Crosse, WI
- Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer - NCT00321685-54601
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer - NCT00265850-54601A
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer - NCT00265850-54601B
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Changes in DNA After Radiation Therapy in Patients With Prostate Cancer - NCT00899912-54601
Conditions: Prostate Cancer
Location: La Crosse, WI
- Chemotherapy or Observation in Treating Patients With Stage I Non-Small Cell Lung Cancer - NCT00863512-54601
Conditions: Lung Cancer
Location: La Crosse, WI
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery - NCT00324805-54601A
Conditions: Lung Cancer
Location: La Crosse, WI
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery - NCT00324805-54601B
Conditions: Lung Cancer
Location: La Crosse, WI
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer - NCT00887159-54601
Conditions: Lung Cancer
Location: La Crosse, WI
- Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer - NCT00083161-54601
Conditions: Lung Cancer
Location: La Crosse, WI
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - NCT00079274-54601A
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - NCT00079274-54601B
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Cyclophosphamide and Doxorubicin or Paclitaxel in Treating Women With Breast Cancer - NCT00041119-54601A
Conditions: Breast Cancer
Location: La Crosse, WI
- Cyclophosphamide and Doxorubicin or Paclitaxel in Treating Women With Breast Cancer - NCT00041119-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery - NCT00700882-54601
Conditions: Melanoma (Skin)
Location: La Crosse, WI
- Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma - NCT00423735-54601
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, WI
- Detection of LAA Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram - NCT00797576-54601
Conditions: Left Atrial Appendage Thrombi
Location: La Crosse, WI
- Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy - NCT00134056-54601
Conditions: Metastatic Cancer - Prostate Cancer
Location: La Crosse, WI
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer - NCT00338247-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Effect on Primary Dysmenorrhea - NCT00909857-54601
Conditions: Primary Dysmenorrhea
Location: La Crosse, WI
- Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer - NCT00265759-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia - NCT00602459-54601
Conditions: Leukemia
Location: La Crosse, WI
- Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive - NCT00390455-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes - NCT00460356-54601
Conditions: Cervical Cancer
Location: La Crosse, WI
- Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer - NCT00068601-54601
Conditions: Breast Cancer - Menopausal Symptoms - Sexual Dysfunction and Infertility
Location: La Crosse, WI
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma - NCT00003641-54601
Conditions: Melanoma (Skin)
Location: La Crosse, WI
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) - NCT00310180-54601A
Conditions: Breast Cancer
Location: La Crosse, WI
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) - NCT00310180-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer - NCT00063882-54601A
Conditions: Prostate Cancer
Location: La Crosse, WI
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer - NCT00063882-54601B
Conditions: Prostate Cancer
Location: La Crosse, WI
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-54601
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: La Crosse, WI
- Letrozole After Tamoxifen in Treating Women With Breast Cancer - NCT00003140-54601A
Conditions: Breast Cancer
Location: La Crosse, WI
- Letrozole After Tamoxifen in Treating Women With Breast Cancer - NCT00003140-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip - NCT00809354-54650
Conditions: Osteoarthritis - Arthritis
Location: Onalaska, WI
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis - NCT00413699-54650
Conditions: Arthritis, Rheumatoid
Location: Onalaska, WI
- Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550 - NCT00414661-54650
Conditions: Arthritis, Rheumatoid
Location: Onalaska, WI
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma - NCT00602641-54601
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: La Crosse, WI
- NINDS CRC Chronic Migraine Treatment Trial - NCT00772031-54601
Conditions: Chronic Migraine
Location: La Crosse, WI
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma - NCT00895622-54601
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, WI
- Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - NCT00217737-54601A
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - NCT00217737-54601B
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer - NCT00803062-54601
Conditions: Cervical Cancer
Location: La Crosse, WI
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer - NCT00108745-54601
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: La Crosse, WI
- Paclitaxel With or Without Sorafenib in Treating Patients With Locally Recurrent or Metastatic Breast Cancer - NCT00499525-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma - NCT00049530-54601
Conditions: Melanoma (Skin)
Location: La Crosse, WI
- Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer - NCT00454194-54601
Conditions: Lung Cancer
Location: La Crosse, WI
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - NCT00074282-54601
Conditions: Leukemia
Location: La Crosse, WI
- Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects - NCT00888069-54601
Conditions: Chronic Kidney Disease - Secondary Hyperparathyroidism - Chronic Renal Insufficiency - Chronic Renal Failure
Location: La Crosse, WI
- Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance - NCT00309933-54601
Conditions: Breast Cancer - Cancer Survivor - Cognitive/Functional Effects - Psychosocial Effects of Cancer and Its Treatment - Sexuality and Reproductive Issues - Spiritual Concerns
Location: La Crosse, WI
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer - NCT00058474-54601A
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer - NCT00058474-54601B
Conditions: Colorectal Cancer
Location: La Crosse, WI
- Radiation Therapy in Treating Patients With Stage II Prostate Cancer - NCT00331773-54601
Conditions: Prostate Cancer
Location: La Crosse, WI
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer - NCT00103181-54601A
Conditions: Breast Cancer
Location: La Crosse, WI
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer - NCT00103181-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer - NCT00492778-54601
Conditions: Endometrial Cancer
Location: La Crosse, WI
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy - NCT00769379-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma - NCT00118209-54601
Conditions: Lymphoma
Location: La Crosse, WI
- Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma - NCT00335140-54601
Conditions: Lymphoma
Location: La Crosse, WI
- Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma - NCT00460109-54601
Conditions: Lymphoma
Location: La Crosse, WI
- Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) - NCT00879333-54601
Conditions: Advanced Gastric Cancer
Location: LaCrosse, WI
- Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Toddlers - NCT00626327-54601
Conditions: Meningococcal Infections
Location: LaCrosse, WI
- SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717) - NCT00798213-54601
Conditions: Leukemia, Myeloid, Acute - Lymphoblastic Leukemia, Acute
Location: La Crosse, WI
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer - NCT00008385-54601A
Conditions: Lung Cancer
Location: La Crosse, WI
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer - NCT00008385-54601B
Conditions: Lung Cancer
Location: La Crosse, WI
- Single-Fraction Radiation Therapy Compared With Multiple-Fraction Reirradiation Therapy in Treating Patients With Painful Bone Metastases - NCT00080912-54601
Conditions: Metastatic Cancer - Pain
Location: La Crosse, WI
- Study of A3309 in Patients With Chronic Idiopathic Constipation - NCT01007123-54601
Conditions: Constipation - Chronic Constipation
Location: La Crosse, WI
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci - NCT00428844-54601
Conditions: Osteomyelitis
Location: La Crosse, WI
- Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer - NCT00687297-54601
Conditions: Lung Cancer - Non Small Cell Lung Cancer
Location: La Crosse, WI
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy - NCT00693992-54601
Conditions: Lung Cancer
Location: La Crosse, WI
- Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery - NCT00326898-54601A
Conditions: Kidney Cancer
Location: La Crosse, WI
- Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery - NCT00326898-54601B
Conditions: Kidney Cancer
Location: La Crosse, WI
- Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer - NCT00066690-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer - NCT00881361-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer - NCT00601900-54601
Conditions: Breast Cancer
Location: La Crosse, WI
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma - NCT00884741-54601
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, WI
- Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission - NCT00093470-54601
Conditions: Leukemia - Myelodysplastic Syndromes
Location: La Crosse, WI
- To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada) - NCT00754065-54601
Conditions: Contraceptive
Location: La Crosse, WI
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) - NCT00938717-54601
Conditions: Irritable Bowel Syndrome With Constipation
Location: La Crosse, WI
- Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy - NCT00450411-54601
Conditions: Prostate Cancer
Location: La Crosse, WI
- US Cycle Control and Blood Pressure Study - NCT00920985-54601
Conditions: Contraception
Location: La Crosse, WI
- Varenicline and Bupropion for Smoking Cessation - NCT00935818-54601
Conditions: Smoking
Location: LaCrosse, WI
- VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer - NCT00357760-54601
Conditions: Kidney Cancer
Location: La Crosse, WI
- Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma - NCT00937495-54601
Conditions: Sarcoma
Location: La Crosse, WI
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases - NCT00079001-54601
Conditions: Metastatic Cancer - Prostate Cancer
Location: La Crosse, WI
- Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer - NCT00127205-54601A
Conditions: Breast Cancer
Location: La Crosse, WI
- Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer - NCT00127205-54601B
Conditions: Breast Cancer
Location: La Crosse, WI
- Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer - NCT00365105-54601
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Pain - Prostate Cancer
Location: La Crosse, WI
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement - NCT00869206-54601
Conditions: Breast Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Musculoskeletal Complications - Pain - Prostate Cancer - Urinary Complications
Location: La Crosse, WI
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|